Purchase Order 75N92025P00032

Award Date 1/1/25
Potential Completion Date 4/28/25
Potential Value $57K
Ultimate Awardee
Becton, Dickinson & Co
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Franklin Lakes, NJ 07417, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $17,118.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) to provide a service contract to maintain a flow cytometer. The contract period of performance is June 2, 2025 through June 1, 2026. No set-aside designation was used for this award. BD is a global medical technology company that develops, manufactures, and sells medical devices,...
This is a $460,479.60 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the service and maintenance of a BD FACSymphony S6 cell sorter. The contract has a period of performance through June 18, 2027 and is not designated as a set-aside. BD, a global medical technology company, will provide preventive maintenance, emergency repairs, software...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $33,675.60. The contract is for BD Biosciences, a division of BD, to provide biomedical instruments, reagents, and services that support flow cytometry, cell imaging, and genomics technologies. BD has extensive experience providing specialized equipment and consumables to support...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm-fixed price purchase order contract to Becton, Dickinson And Company (BD) on November 1, 2017 for $162,540.00. The contract is for FACSARIA SERVICE and has an end date of October 31, 2022. BD, a global medical technology company, is providing the government with specialized equipment, reagents, and services related to flow cytometry, cell imaging, and genomics...
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $125,877.00. The contract is for an annual service agreement to maintain BD's FACS (fluorescence-activated cell sorting) flow machines and accessories used to support biomedical research and clinical applications at NIAID. The contract does not have a set-aside designation. BD is...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) for a FACS ARIA 2 service agreement. The contract has a ceiling value of $58,752.00 and an ultimate completion date of November 30, 2018. BD is a global medical technology company that provides instruments, reagents, and services to support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
This is a federal contract award to Becton, Dickinson and Company (BD), a global medical technology company, by the National Institutes of Health (NIH) Clinical Center. The $66,373.80 firm fixed-price purchase order is for the delivery of flow cytometry instruments, maintenance services, and related consumables to support biomedical research and clinical applications across various NIH components, including the National Institute of Allergy and Infectious Diseases (NIAID), National Cancer...
This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD). The contract, valued at $620,350.80, is for extended warranty maintenance support for BD's flow cytometry equipment, including the FACSAria II, FACSCanto II, FACSAria Fusion, and FACS Symphony A3 systems. The contract has a period of performance through July 11, 2027. This award was not set aside for...
This is a firm fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The $21,900.48 contract is for a service contract to maintain the NHLBI's FACS Fortessa X-20 SORP flow cytometry instrument. This contract does not have a set-aside designation, indicating it was competed on a full and open basis. BD, a...

This is a $57,272.40 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for ARIA-2 cell sorter service and maintenance. The contract has an ultimate completion date of April 28, 2025. BD is a global medical technology company that specializes in flow cytometry instrumentation, cell imaging, and genomics. The company has an extensive history of providing specialized scientific equipment and related services to federal agencies, including multiple NIH components like the National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases (NIAID). This contract does not have a set-aside designation, indicating BD's competitive position in the federal medical technology market. The award appears to be part of BD's broader portfolio of federal Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with agencies like the Department of Veterans Affairs and NIH Clinical Center, which provide flexible procurement mechanisms for accessing the company's specialized products and services.

Generated 4/30/25, 10:24 AM